|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
PRECEPT
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fundamental principles of descriptive and inferential statistics, measurement, design, and analysis |
Application of these principles to specific areas:
|
Clinical Trials Goals and Objectives
To expose participants to the relevance of the Food and Drug Act to the design and conduct of clinical trials. |
|
|
|
To convey an understanding of the differences between Phase I, II, III, and IV Clinical Trials. |
|
|
|
To develop a framework for understanding data management techniques, at both the macro (rapidly evolving technologies) and the micro (individual trials) level. |
|
|
|
To emphasize the practical aspects of conducting clinical trials and how to avoid pitfalls and the need for rework. |
|
|
|
To explore methods of conducting trials in complex patients and how to "connect" with national studies and industry. |
|
|
|
To understand methods of translating the results of clinical trials to improved health and optimal patient outcomes. |
Registration and Lecture Information
Lectures are one hour with discussion to follow and are delivered on Thursdays from 5:30pm - 7:00 pm, except the lecture on 11/30/06 will be from 5:00-6:15. Complete course materials will be available at the beginning of each lecture if applicable.
9/28/06 |
|
|
10/05/06 |
|
10/12/06 |
|
|
10/19/06 |
|
|
11/02/06 |
|
|
11/09/06 |
|
|
11/16/06 |
|
|
11/30/06 |
|
|
12/07/06 |
|